You haven't searched anything yet.
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade.
R&D is committed to discovering and delivering transformational vaccines and medicines to prevent and change the course of disease.
Science and technology are coming together in a way they never have before, and we have strong tech-enabled capabilities that allow us to build a deeper understanding of the patient, human biology and disease mechanisms, and transform medical discovery.
We are revolutionising the way we do R&D. We’re uniting science, technology and talent to get ahead of disease together.
The Expanded Access Coordinator (Oncology) is responsible for providing operational support for Managed access Programs, including Compassionate Use, Expanded Access, and Post Trial access.
As part of the Managed Access Team, the Coordinator Managed Access will be responsible for establishing strong relationships with internal cross functional teams including local medical teams, supply, finance and governance teams, as well as communication with HCPs and other external stakeholders.
Key Responsibilities :
Set up and manage operational support for access programs from planning through close out, including such activities as invoice and PO management, GSK CTMS systems, vendor communications, IP stock and delivery, as well as the tracking of documents, agreements, contracts and key correspondence.
This role interacts with many internal and external cross functional teams.
Provide regular status updates on program utilization to internal stakeholders
Basic Qualifications :
Preferred Qualifications :
Please visit to learn more about the comprehensive benefits program GSK offers US employees.
Why GSK?
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a special purpose to unite science, technology and talent to get ahead of disease together so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns as an organisation where people can thrive.
We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory / immunology and oncology).
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive.
We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves feeling welcome, valued, and included.
Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.
GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity / expression, age, disability, genetic information, military service, covered / protected veteran status or any other federal, state or local protected class.
Important notice to Employment businesses / Agencies
All employment businesses / agencies are required to contact GSK's commercial and general procurement / human resources department to obtain prior written authorization before referring any candidates to GSK.
The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business / agency and GSK.
In the absence of such written authorization being obtained any actions undertaken by the employment business / agency shall be deemed to have been performed without the consent or contractual agreement of GSK.
Last updated : 2024-05-08
Full Time
$46k-55k (estimate)
05/09/2024
05/15/2024